Plavix

Drug Overview
Product Profiles
Plavix: Stroke
Plavix: Acute coronary syndrome

Figure 1: Plavix for ischemic stroke – SWOT analysis
Figure 2: The authors drug assessment summary of Plavix for ischemic stroke
Figure 3: The authors drug assessment summary of Plavix for ischemic stroke
Figure 4: Plavix sales for ischemic stroke across the US, Japan, and five major EU markets, by country, 2016–25
Figure 5: Plavix for acute coronary syndrome – SWOT analysis
Figure 6: The authors drug assessment summary for Plavix in acute coronary syndrome
Figure 7: The authors drug assessment summary for Plavix in acute coronary syndrome

Table 1: Plavix drug profile
Table 2: Plavix pivotal trial data in ischemic stroke
Table 3: Plavix ongoing late-phase clinical trials in ischemic stroke
Table 4: Plavix sales for ischemic stroke across the US, Japan, and five major EU markets, by country, 2016–25
Table 5: Plavix drug profile
Table 6: Plavix pivotal trial data in acute coronary syndrome